Evidence map›Paper›PMID 41961483›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

ERK-Mediated Phosphorylation of YAP Defines a Noncanonical FGF Signaling Mechanism in Stem Cells.

Xiaolei Zhao, Shannon Erhardt, Li Tang, Xiaotong Chen, Stephen M Farmer, Zixiu Cheng, Wen Chen, Ella Ziyuan Lu, Kihan Sung, Chang-Ru Tsai and 7 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xiaolei ZhaoDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.ORCID https://orcid.org/0000-0002-4697-3874
Shannon ErhardtDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.ORCID https://orcid.org/0000-0002-0189-0012
Li Tang(Currently) Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
Xiaotong ChenDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.
Stephen M FarmerMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas, Houston, Texas, USA.
Zixiu ChengDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.
Wen ChenDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.
Ella Ziyuan LuDepartment of BioSciences, Rice University, Houston, Texas, USA.
Kihan SungDepartment of BioSciences, Rice University, Houston, Texas, USA.
Chang-Ru TsaiDepartment of Integrative Physiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas, USA.
Mingjie ZhengDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.
Sheng ZhangMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas, Houston, Texas, USA.
Yang LiuMD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas, Houston, Texas, USA.
Jianxin WangHunan Provincial Key Lab on Bioinformatics, School of Computer Science and Engineering, Central South University, Changsha, Hunan, China.
Min LiHunan Provincial Key Lab on Bioinformatics, School of Computer Science and Engineering, Central South University, Changsha, Hunan, China.
James F MartinDepartment of Integrative Physiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas, USA.
Jun WangDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center At Houston (UTHealth), Houston, Texas, USA.ORCID https://orcid.org/0000-0001-6874-9331

Funding

Genetic dissection of Cardiac Conduction System homeostasis and RepairR01HL142704 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Jun Wang · 2020 to 2026
$3.0M
Molecular Regulatory Mechanism of Cranial Neural Crest DevelopmentR01DE029014 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WANG, JUN · 2020 to 2024
$1.8M
A Hippo-Yap Pathway in Cranial Bone Development and RegenerationK01DE026561 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WANG, JUN · 2017 to 2021
$739k
A signaling crosstalk regulation in neural crest-derived cranial sutureK99DE033506 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHAO, XIAOLEI · 2024 to 2025
$215k
Investigating the role of Yap/Taz in neural crest-derived cardiac developmentF31HL176166 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Shannon Nicole Erhardt · 2024 to 2026
$113k
NIDCR NIH HHS K99 DE033506NIH HHS F31HL176166NIH HHS K01DE026561NIH HHS K99DE033506NIH HHS R01DE029014NIH HHS R01HL142704
6 · The paper itself

Abstract

While Fgf and Hippo-Yap signaling are fundamental for proper development, homeostasis, and disease, their crosstalk remains largely unknown. Here, we identified that Yap and Taz, canonical Hippo effectors, function as noncanonical effectors of Fgf signaling to maintain the proper function of neural crest (NC) lineages. NC cells are a multipotent stem cell population during vertebrate embryogenesis that contribute to numerous structures and diverse cell lineages, including craniofacial and cardiac tissues, neurons, and suture mesenchymal cells (SMCs), a specified cell population required for cranial bone growth and repair. We observed that activation of Fgf signaling in NC cells and NC-derived SMCs inhibited osteogenesis while simultaneously enhancing stemness and proliferation. Interestingly, these effects were reversed by inhibition of either Yap/Taz or phosphorylated Erk1/2 (pErk1/2). Mechanistically, Fgf signaling promotes the interaction of Yap and pErk1/2, increasing the chromatin occupancy of Yap at genes regulating stemness, proliferation, and osteogenesis. We further show that pERK1/2 phosphorylates YAP at the noncanonical S128 site, enhancing YAP's nuclear localization. This mechanism is conserved across mouse and human cells and is active in Apert syndrome-associated FGF gain-of-function models, revealing a previously unrecognized FGF-YAP axis in stem cell regulation.

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsFibroblast Growth FactorsMAP Kinase Signaling SystemNeural CrestStem CellsTranscription FactorsAnimalsCell ProliferationHumansMiceOsteogenesisPhosphorylationSignal TransductionYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsFibroblast Growth FactorsTranscription FactorsYap1 protein, mouseYAP-Signaling ProteinsERKFGF signalingneural crest cellsuture mesenchymal cellsYAP

Identifiers

PMID41961483
PMCPMC13334658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.